Corporate Governance Statement 2023 28 August 202325 August 2023 by Audrey Thomson Corporate Governance Statement 2023
Year End Accounts and Preliminary Final Report 28 August 202325 August 2023 by Audrey Thomson Year End Accounts and Preliminary Final Report
Completion of Phase 2 COVID Clinical Trial 16 August 2023 by Audrey Thomson Completion of Phase 2 COVID Clinical Trial
Report on Activities for the Quarter ended 30 June 2023 28 July 2023 by Audrey Thomson Report on Activities for the Quarter Ended 30 June 2023
Quarterly Report 30 June 2023 27 October 202328 July 2023 by Audrey Thomson Quarterly Report 30 June 2023
Second Site Approved for Phase 2 COVID-19 Trial 12 May 2023 by Audrey Thomson Second Site Approved for Phase 2 COVID-19 Trial
Commencement of Phase 2 COVID-19 Clinical Trial 4 May 2023 by Audrey Thomson Commencement of Phase 2 COVID-19 Clinical Trial
Report on Activities for the Quarter ended 31 March 2023 27 April 2023 by Audrey Thomson Report on Activities for the Quarter Ended 31 March 2023